Sponsored Resources

Propelling R&D for Novel Retinal Therapies Through Innovative Clinical Trial Design

ByPeter K. Kaiser, MD,Jeffrey Heier, MD,Nadia K. Waheed, MD, MPH

July 28th 2025

Could targeting retinal non-perfusion be the key to achieving true disease modification in diabetic retinopathy?

July 17th 2025

Real World insights with EYLEA 8mg

ByDr Peter Kaiser, Cole Eye Institute, Cleveland Clinic, USA

July 14th 2025

EYLEA 8mg in focus: Key learnings from the pivotal trials

ByProfessor Varun Chaudhary, McMaster University, Canada

June 5th 2025

A Turning Point in Retinal Neovascular Diseases

BySponsored by Bayer

April 11th 2025

EYLEA’s unique MoA: What is the rationale for the higher molar dose?

ByProfessor Jean-Francois Korobelnik, University Hospital of Bordeaux, France

January 23rd 2025

Is Artificial Intelligence (AI) the solution to saving ophthalmologists’ time?

June 5th 2024

Data from self-tonometry supports glaucoma treatment decisions

May 1st 2024

An ophthalmologist with personal experience has explored the impact of AI-driven solutions

March 1st 2024

Setting a New Standard in Automated Tracked Perimetry

ByDr. Luca Rossetti

November 1st 2023

Innovative new features build on the benefits of the iCare COMPASS Automated Perimeter

iCare HOME tonometers optimize patient care

June 1st 2023

Self-tonometry provides invaluable insights into IOP fluctuations

December 1st 2022

A HISTORY OF DISCOVERY: Why AbbVie focuses on challenging eye care diseases

December 1st 2022

Biosimilars- What Clinicians Should Know

November 30th 2022

Insights on Treating Patients with Macular Edema Associated with Noninfectious Uveitis

May 9th 2022

Staying at the top: Optimizing clinical care and practice efficiency with multimodal Triton™ imaging

Taking Visual Field Analysis to a Higher Level with the iCare COMPASS Automated Perimeter

April 29th 2022

Staying at the top: Optimizing clinical care and practice efficiency with multimodal Triton™ imaging

February 11th 2022

Updates From Angiogenesis 2022

February 11th 2022

Staying at the top: Empowering Providers with the Multimodal Maestro2

January 19th 2022

Biosimilars: What Clinicians Should Know

January 7th 2022

Maximizing treatment benefits and unlocking the potential of proactive extended dosing for patients with retinal disease

December 3rd 2021

Broadening the benefits of iCare EIDON retinal imaging with the new Ultra-Wide Field Module

ByAdvertorial

October 29th 2021

This article is produced by iCare Finland for healthcare professionals and is not intended to provide medical advice and/or treatment guidance. This website is not country-specific and therefore may contain information which is not applicable to your country.

Updates from ASRS 2021

October 28th 2021

UNCOVERING HIDDEN PREDATORS IN DISEASE

ByRoche

August 10th 2021

This article is produced by Roche for healthcare professionals and is not intended to provide medical advice and/or treatment guidance. This website is not country-specific and therefore may contain information which is not applicable to your country.

Sponsored Resources

Propelling R&D for Novel Retinal Therapies Through Innovative Clinical Trial Design

Could targeting retinal non-perfusion be the key to achieving true disease modification in diabetic retinopathy?

Real World insights with EYLEA 8mg

EYLEA 8mg in focus: Key learnings from the pivotal trials

A Turning Point in Retinal Neovascular Diseases

EYLEA’s unique MoA: What is the rationale for the higher molar dose?

Is Artificial Intelligence (AI) the solution to saving ophthalmologists’ time?

Data from self-tonometry supports glaucoma treatment decisions

An ophthalmologist with personal experience has explored the impact of AI-driven solutions

Setting a New Standard in Automated Tracked Perimetry

iCare HOME tonometers optimize patient care

Self-tonometry provides invaluable insights into IOP fluctuations

A HISTORY OF DISCOVERY: Why AbbVie focuses on challenging eye care diseases

Biosimilars- What Clinicians Should Know

Insights on Treating Patients with Macular Edema Associated with Noninfectious Uveitis

Taking Visual Field Analysis to a Higher Level with the iCare COMPASS Automated Perimeter

Staying at the top: Optimizing clinical care and practice efficiency with multimodal Triton™ imaging

Updates From Angiogenesis 2022

Staying at the top: Empowering Providers with the Multimodal Maestro2

Biosimilars: What Clinicians Should Know

Maximizing treatment benefits and unlocking the potential of proactive extended dosing for patients with retinal disease

Broadening the benefits of iCare EIDON retinal imaging with the new Ultra-Wide Field Module

Updates from ASRS 2021

UNCOVERING HIDDEN PREDATORS IN DISEASE

Updates From Angiogenesis 2021

Evolving Clinical Practice: Insights Gained from Real-World Evidence

Navigating Real-World Evidence in Ophthalmology

Conducting An Audit and Using Real-World Evidence in Your Practice

Optimizing Retinal Disease Management in Real-world Clinical Practice

Retina in 2020 and Beyond

Trending on Modern Retina

Aviceda Therapeutics reports positive phase 2b SIGLEC results for AVD-104 in geographic atrophy

Timely interventions can protect vision in patients with GA

Monitoring MacTel: Why BCVA does not tell the whole story

Enhancing Durability and Fluid Control with Aflibercept 8 mg in Retinal Vascular Diseases

Ocular Therapeutix accelerates NDA submission plans for AXPAXLI for wet AMD